These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31220951)

  • 1. Proteomic signatures of neuroinflammation in Alzheimer's disease, multiple sclerosis and ischemic stroke.
    Thygesen C; Larsen MR; Finsen B
    Expert Rev Proteomics; 2019 Jul; 16(7):601-611. PubMed ID: 31220951
    [No Abstract]   [Full Text] [Related]  

  • 2. Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid.
    Bastos P; Ferreira R; Manadas B; Moreira PI; Vitorino R
    Crit Rev Clin Lab Sci; 2017 May; 54(3):185-204. PubMed ID: 28393582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omics-Based Approach Reveals Complement-Mediated Inflammation in Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS).
    Blaabjerg M; Hemdrup AL; Drici L; Ruprecht K; Garred P; Höftberger R; Kristensen BW; Kondziella D; Sejbaek T; Hansen SW; Nielsen HH; Jensen P; Meyer M; Paul F; Lassmann H; Larsen MR; Illes Z
    Front Immunol; 2018; 9():741. PubMed ID: 29740431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative clinical proteomic study of autopsied human infarcted brain specimens to elucidate the deregulated pathways in ischemic stroke pathology.
    Datta A; Akatsu H; Heese K; Sze SK
    J Proteomics; 2013 Oct; 91():556-68. PubMed ID: 24007662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteins.
    Rangaraju S; Dammer EB; Raza SA; Gao T; Xiao H; Betarbet R; Duong DM; Webster JA; Hales CM; Lah JJ; Levey AI; Seyfried NT
    Mol Neurodegener; 2018 Jun; 13(1):34. PubMed ID: 29954413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting Alzheimer's Disease Molecular Substrates by Proteomics and Discovery of Novel Post-translational Modifications.
    Deolankar SC; Patil AH; Koyangana SG; Subbannayya Y; Prasad TSK; Modi PK
    OMICS; 2019 Jul; 23(7):350-361. PubMed ID: 31225774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases.
    Baldacci F; Lista S; Cavedo E; Bonuccelli U; Hampel H
    Expert Rev Proteomics; 2017 Apr; 14(4):285-299. PubMed ID: 28281838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.
    Robinson RA; Amin B; Guest PC
    Adv Exp Med Biol; 2017; 974():21-48. PubMed ID: 28353223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined tissue and fluid proteomics with Tandem Mass Tags to identify low-abundance protein biomarkers of disease in peripheral body fluid: An Alzheimer's Disease case study.
    Russell CL; Heslegrave A; Mitra V; Zetterberg H; Pocock JM; Ward MA; Pike I
    Rapid Commun Mass Spectrom; 2017 Jan; 31(2):153-159. PubMed ID: 27813239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common Peripheral Immunity Mechanisms in Multiple Sclerosis and Alzheimer's Disease.
    Rossi B; Santos-Lima B; Terrabuio E; Zenaro E; Constantin G
    Front Immunol; 2021; 12():639369. PubMed ID: 33679799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological implications of actin-free Gc-globulin concentration changes in blood plasma and cerebrospinal fluid collected from patients with Alzheimer's disease and other neurological disorders.
    Kułakowska A; Tarasiuk J; Kapica-Topczewska K; Chorąży M; Pogorzelski R; Kulczyńska-Przybik A; Mroczko B; Bucki R
    Adv Clin Exp Med; 2018 Aug; 27(8):1075-1080. PubMed ID: 29905407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential Features and Use Cases of the Cerebrospinal Fluid Proteome Resource (CSF-PR).
    Guldbrandsen A; Farag YM; Lereim RR; Berven FS; Barsnes H
    Methods Mol Biol; 2019; 2044():377-391. PubMed ID: 31432427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer's disease and multiple sclerosis: a systematic review.
    Temmerman J; Engelborghs S; Bjerke M; D'haeseleer M
    Front Immunol; 2023; 14():1162340. PubMed ID: 37520580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease.
    Higginbotham L; Ping L; Dammer EB; Duong DM; Zhou M; Gearing M; Hurst C; Glass JD; Factor SA; Johnson ECB; Hajjar I; Lah JJ; Levey AI; Seyfried NT
    Sci Adv; 2020 Oct; 6(43):. PubMed ID: 33087358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale informatic analysis to algorithmically identify blood biomarkers of neurological damage.
    O'Connell GC; Alder ML; Smothers CG; Chang JHC
    Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20764-20775. PubMed ID: 32764143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Top-down proteomic profiling of human saliva in multiple sclerosis patients.
    Manconi B; Liori B; Cabras T; Vincenzoni F; Iavarone F; Lorefice L; Cocco E; Castagnola M; Messana I; Olianas A
    J Proteomics; 2018 Sep; 187():212-222. PubMed ID: 30086402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an update.
    Portelius E; Brinkmalm G; Pannee J; Zetterberg H; Blennow K; Dahlén R; Brinkmalm A; Gobom J
    Expert Rev Proteomics; 2017 Nov; 14(11):1007-1020. PubMed ID: 28942688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease.
    Mendonça CF; Kuras M; Nogueira FCS; Plá I; Hortobágyi T; Csiba L; Palkovits M; Renner É; Döme P; Marko-Varga G; Domont GB; Rezeli M
    Neurobiol Dis; 2019 Oct; 130():104509. PubMed ID: 31207390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic Approaches to Decipher Mechanisms Underlying Pathogenesis in Multiple Sclerosis Patients.
    Singh V; Tripathi A; Dutta R
    Proteomics; 2019 Aug; 19(16):e1800335. PubMed ID: 31119864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's disease.
    Hölttä M; Minthon L; Hansson O; Holmén-Larsson J; Pike I; Ward M; Kuhn K; Rüetschi U; Zetterberg H; Blennow K; Gobom J
    J Proteome Res; 2015 Feb; 14(2):654-63. PubMed ID: 25490617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.